Dr. Dina Alnuaimi | Senior Pharmacist- Drug Department, Head of Medical Supply Chain ,Policies and Standards
Emirates Health Services, UAE

Dr. Dina Alnuaimi is a healthcare management and pharmaceutical supply chain leader at Emirates Health Services, bringing over two decades of experience in healthcare operations, policy development, and supply chain optimization across the UAE. She currently serves in the Policies and Standards Department, where she develops and implements clinical and operational standards to improve quality, efficiency, and regulatory compliance in healthcare settings.
She began her career as a pharmacist and advanced into senior leadership roles, heading multiple critical supply chain and procurement divisions. She has led strategic initiatives in inventory management, vendor negotiations, and quality assurance, demonstrating expertise in regulatory compliance, risk management, data-driven decision-making, and healthcare digital transformation.
With over 20 years of experience in pharmacy and supply-chain leadership, she excels in healthcare policy development, regulatory compliance, and operational optimization.
Dr. Alnuaimi holds a PhD in Healthcare Management and an MSc in Public Health, alongside a Bachelor’s in Pharmacy and Health Science. Dr. Alnuaimi combines academic insight with real-world healthcare logistics to drive innovation in health services.
Her doctoral research explored the impacts of Enterprise Resource Planning (ERP) systems on healthcare supply chain performance, providing evidence-based strategies for enhancing efficiency, resilience, and service quality.
An accomplished researcher and author, Dr. Alnuaimi has published extensively on topics including ERP adoption, healthcare supply chain digitalization, and the application of big data analytics in healthcare logistics. As a sought-after speaker and educator, she has presented at regional conferences and delivered lectures on supply chain resilience, healthcare digitalization, and policy development.
At ARABLAB LIVE 2025, she will share her insights on pharmaceutical testing practices, regulatory expectations, and emerging trends — drawing on her unique blend of hands-on operational expertise, strategic policy experience, and cutting-edge research to inspire innovation in healthcare and laboratory services.